US Stock MarketDetailed Quotes

ABEO Abeona Therapeutics

Watchlist

6.6700
-0.0700-1.04%

Close Oct 18 16:00 ET

6.6700
0.00000.00%

Post 20:02 ET

288.91MMarket Cap-3768P/E (TTM)

Abeona Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-23.34%-12.68M

-23.79%-14.54M

14.89%-37.01M

34.00%-9.24M

15.39%-5.75M

-14.10%-10.28M

14.20%-11.74M

33.78%-43.48M

53.76%-13.99M

34.28%-6.79M

Net income from continuing operations

144.47%7.41M

-246.74%-31.58M

-36.51%-54.19M

-132.99%-16.59M

-83.96%-11.84M

-306.49%-16.65M

58.69%-9.11M

53.26%-39.7M

84.75%-7.12M

8.66%-6.43M

Operating gains losses

-427.54%-24.93M

863.84%17.3M

218.29%10.68M

189.65%4.23M

136.44%1.11M

400.71%7.61M

-280.77%-2.27M

-413.42%-9.03M

---4.71M

---3.04M

Depreciation and amortization

-18.26%685K

-18.47%724K

-30.13%3.2M

-28.54%721K

-30.78%751K

-38.83%838K

-20.22%888K

2.53%4.58M

-15.64%1.01M

0.09%1.09M

Other non cash items

160.54%383K

1,782.35%286K

-8.99%324K

93.34%-119K

146.46%313K

110.88%147K

-100.50%-17K

105.43%356K

-2,568.66%-1.79M

101.88%127K

Change In working capital

177.64%2.45M

-39.94%-2.82M

69.65%-1.79M

125.35%1.02M

183.33%2.36M

-101.21%-3.15M

-74.29%-2.01M

67.74%-5.89M

79.11%-4M

-47.88%834K

-Change in receivables

110.10%552K

436.00%252K

-172.58%-2.04M

-102.33%-20K

97.64%3.52M

-93.28%-5.46M

-102.50%-75K

193.73%2.81M

128.63%859K

--1.78M

-Change in prepaid assets

40.52%593K

-2.75%-1.23M

-107.94%-155K

-26.30%384K

-51.92%238K

-24.37%422K

-416.36%-1.2M

490.03%1.95M

135.44%521K

19.57%495K

-Change in payables and accrued expense

-29.07%1.57M

-349.47%-1.69M

122.41%2.04M

154.81%2.18M

-72.75%-1.98M

215.10%2.21M

91.97%-376K

41.57%-9.11M

72.93%-3.98M

-196.46%-1.15M

-Change in other current assets

255.56%14K

391.07%163K

-287.20%-234K

-500.00%-138K

---31K

---9K

-137.84%-56K

1,885.71%125K

-243.75%-23K

--0

-Change in other current liabilities

10.83%-280K

-0.98%-310K

16.43%-1.4M

-1.16%-1.39M

308.11%616K

---314K

---307K

---1.67M

---1.38M

---296K

Cash from discontinued investing activities

Operating cash flow

-23.34%-12.68M

-23.79%-14.54M

14.89%-37.01M

34.00%-9.24M

15.39%-5.75M

-14.10%-10.28M

14.20%-11.74M

33.78%-43.48M

53.76%-13.99M

34.28%-6.79M

Investing cash flow

Cash flow from continuing investing activities

-946.90%-44.13M

-453.55%-7.82M

100.87%208K

145.59%11.53M

-1,236.63%-18.74M

472.75%5.21M

105.67%2.21M

-136.28%-23.96M

-416.16%-25.29M

-93.84%1.65M

Capital expenditure reported

-2,121.88%-711K

-232.57%-725K

-154.62%-331K

-48.00%-37K

-2,100.00%-44K

---32K

-111.65%-218K

96.87%-130K

99.23%-25K

99.50%-2K

Net PPE purchase and sale

----

-88.24%204K

-88.19%17K

-92.23%8K

----

--1.73M

--144K

--103K

Net investment purchase and sale

-957.80%-43.44M

-391.97%-7.09M

101.31%335K

145.45%11.55M

-1,308.46%-18.71M

275.53%5.06M

106.20%2.43M

-136.41%-25.57M

-325.92%-25.41M

-94.30%1.55M

Cash from discontinued investing activities

Investing cash flow

-946.90%-44.13M

-453.55%-7.82M

100.87%208K

145.59%11.53M

-1,236.63%-18.74M

472.75%5.21M

105.67%2.21M

-136.28%-23.96M

-416.16%-25.29M

-93.84%1.65M

Financing cash flow

Cash flow from continuing financing activities

1,013.39%73.68M

636,100.00%25.44M

-14.17%37.06M

-82.54%7.47M

448.48%22.98M

274.99%6.62M

-4K

73.66%43.17M

161.87%42.77M

2,321.39%4.19M

Net issuance payments of debt

--0

--20M

----

--0

----

Net common stock issuance

1,012.76%73.7M

--6.42M

-20.38%37.39M

-81.80%7.79M

448.58%22.98M

--6.62M

--0

95.42%46.96M

161.90%42.77M

12,593.94%4.19M

Net preferred stock issuance

----

--0

----

---3.78M

--0

Proceeds from stock option exercised by employees

----

-3,540.00%-182K

-3,280.00%-169K

----

-100.60%-5K

---5K

----

Net other financing activities

-180.00%-14K

-24,325.00%-977K

---150K

----

---5K

---4K

----

Cash from discontinued financing activities

Financing cash flow

1,013.39%73.68M

636,100.00%25.44M

-14.17%37.06M

-82.54%7.47M

448.48%22.98M

274.99%6.62M

---4K

73.66%43.17M

161.87%42.77M

2,321.39%4.19M

Net cash flow

Beginning cash position

256.64%17.9M

1.76%14.81M

-62.52%14.56M

-54.39%5.05M

-45.42%6.56M

-80.86%5.02M

-62.52%14.56M

186.12%38.83M

-75.26%11.07M

-57.29%12.02M

Current changes in cash

991.78%16.87M

132.35%3.09M

101.05%256K

180.17%9.76M

-58.76%-1.51M

110.89%1.55M

24.38%-9.54M

-196.10%-24.27M

158.78%3.48M

-105.74%-953K

End cash Position

429.70%34.76M

256.64%17.9M

1.76%14.81M

-54.39%5.05M

-45.42%6.56M

-80.86%5.02M

-62.52%14.56M

-75.26%11.07M

Free cash flow

-29.85%-13.4M

-27.60%-15.26M

14.38%-37.34M

33.85%-9.27M

14.77%-5.79M

-14.46%-10.32M

13.26%-11.96M

37.53%-43.61M

58.16%-14.02M

36.73%-6.79M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-23.34%-12.68M	-23.79%-14.54M	14.89%-37.01M	34.00%-9.24M	15.39%-5.75M	-14.10%-10.28M	14.20%-11.74M	33.78%-43.48M	53.76%-13.99M	34.28%-6.79M
Net income from continuing operations	144.47%7.41M	-246.74%-31.58M	-36.51%-54.19M	-132.99%-16.59M	-83.96%-11.84M	-306.49%-16.65M	58.69%-9.11M	53.26%-39.7M	84.75%-7.12M	8.66%-6.43M
Operating gains losses	-427.54%-24.93M	863.84%17.3M	218.29%10.68M	189.65%4.23M	136.44%1.11M	400.71%7.61M	-280.77%-2.27M	-413.42%-9.03M	---4.71M	---3.04M
Depreciation and amortization	-18.26%685K	-18.47%724K	-30.13%3.2M	-28.54%721K	-30.78%751K	-38.83%838K	-20.22%888K	2.53%4.58M	-15.64%1.01M	0.09%1.09M
Other non cash items	160.54%383K	1,782.35%286K	-8.99%324K	93.34%-119K	146.46%313K	110.88%147K	-100.50%-17K	105.43%356K	-2,568.66%-1.79M	101.88%127K
Change In working capital	177.64%2.45M	-39.94%-2.82M	69.65%-1.79M	125.35%1.02M	183.33%2.36M	-101.21%-3.15M	-74.29%-2.01M	67.74%-5.89M	79.11%-4M	-47.88%834K
-Change in receivables	110.10%552K	436.00%252K	-172.58%-2.04M	-102.33%-20K	97.64%3.52M	-93.28%-5.46M	-102.50%-75K	193.73%2.81M	128.63%859K	--1.78M
-Change in prepaid assets	40.52%593K	-2.75%-1.23M	-107.94%-155K	-26.30%384K	-51.92%238K	-24.37%422K	-416.36%-1.2M	490.03%1.95M	135.44%521K	19.57%495K
-Change in payables and accrued expense	-29.07%1.57M	-349.47%-1.69M	122.41%2.04M	154.81%2.18M	-72.75%-1.98M	215.10%2.21M	91.97%-376K	41.57%-9.11M	72.93%-3.98M	-196.46%-1.15M
-Change in other current assets	255.56%14K	391.07%163K	-287.20%-234K	-500.00%-138K	---31K	---9K	-137.84%-56K	1,885.71%125K	-243.75%-23K	--0
-Change in other current liabilities	10.83%-280K	-0.98%-310K	16.43%-1.4M	-1.16%-1.39M	308.11%616K	---314K	---307K	---1.67M	---1.38M	---296K
Cash from discontinued investing activities
Operating cash flow	-23.34%-12.68M	-23.79%-14.54M	14.89%-37.01M	34.00%-9.24M	15.39%-5.75M	-14.10%-10.28M	14.20%-11.74M	33.78%-43.48M	53.76%-13.99M	34.28%-6.79M
Investing cash flow
Cash flow from continuing investing activities	-946.90%-44.13M	-453.55%-7.82M	100.87%208K	145.59%11.53M	-1,236.63%-18.74M	472.75%5.21M	105.67%2.21M	-136.28%-23.96M	-416.16%-25.29M	-93.84%1.65M
Capital expenditure reported	-2,121.88%-711K	-232.57%-725K	-154.62%-331K	-48.00%-37K	-2,100.00%-44K	---32K	-111.65%-218K	96.87%-130K	99.23%-25K	99.50%-2K
Net PPE purchase and sale	----	----	-88.24%204K	-88.19%17K	-92.23%8K	----	----	--1.73M	--144K	--103K
Net investment purchase and sale	-957.80%-43.44M	-391.97%-7.09M	101.31%335K	145.45%11.55M	-1,308.46%-18.71M	275.53%5.06M	106.20%2.43M	-136.41%-25.57M	-325.92%-25.41M	-94.30%1.55M
Cash from discontinued investing activities
Investing cash flow	-946.90%-44.13M	-453.55%-7.82M	100.87%208K	145.59%11.53M	-1,236.63%-18.74M	472.75%5.21M	105.67%2.21M	-136.28%-23.96M	-416.16%-25.29M	-93.84%1.65M
Financing cash flow
Cash flow from continuing financing activities	1,013.39%73.68M	636,100.00%25.44M	-14.17%37.06M	-82.54%7.47M	448.48%22.98M	274.99%6.62M	-4K	73.66%43.17M	161.87%42.77M	2,321.39%4.19M
Net issuance payments of debt	--0	--20M	----	----	----	--0	--0	----	----	----
Net common stock issuance	1,012.76%73.7M	--6.42M	-20.38%37.39M	-81.80%7.79M	448.58%22.98M	--6.62M	--0	95.42%46.96M	161.90%42.77M	12,593.94%4.19M
Net preferred stock issuance	----	----	--0	--0	----	----	----	---3.78M	--0	--0
Proceeds from stock option exercised by employees	----	----	-3,540.00%-182K	-3,280.00%-169K	----	----	----	-100.60%-5K	---5K	----
Net other financing activities	-180.00%-14K	-24,325.00%-977K	---150K	----	----	---5K	---4K	----	----	----
Cash from discontinued financing activities
Financing cash flow	1,013.39%73.68M	636,100.00%25.44M	-14.17%37.06M	-82.54%7.47M	448.48%22.98M	274.99%6.62M	---4K	73.66%43.17M	161.87%42.77M	2,321.39%4.19M
Net cash flow
Beginning cash position	256.64%17.9M	1.76%14.81M	-62.52%14.56M	-54.39%5.05M	-45.42%6.56M	-80.86%5.02M	-62.52%14.56M	186.12%38.83M	-75.26%11.07M	-57.29%12.02M
Current changes in cash	991.78%16.87M	132.35%3.09M	101.05%256K	180.17%9.76M	-58.76%-1.51M	110.89%1.55M	24.38%-9.54M	-196.10%-24.27M	158.78%3.48M	-105.74%-953K
End cash Position	429.70%34.76M	256.64%17.9M	1.76%14.81M	1.76%14.81M	-54.39%5.05M	-45.42%6.56M	-80.86%5.02M	-62.52%14.56M	-62.52%14.56M	-75.26%11.07M
Free cash flow	-29.85%-13.4M	-27.60%-15.26M	14.38%-37.34M	33.85%-9.27M	14.77%-5.79M	-14.46%-10.32M	13.26%-11.96M	37.53%-43.61M	58.16%-14.02M	36.73%-6.79M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data